Is tissue cross-talk important in cancer cachexia?

Critical Reviews in Oncogenesis

Volumn 17, Issue 3, 2012, Pages 263-276

  Johns, N ^a   Greig, C A ^a   Fearon, K C H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Adipokines; Cachexia; Cancer; Myokines; Skeletal muscle

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; FATTY ACID; GLUCOSE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; RESISTIN; STAT PROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; VERY LOW DENSITY LIPOPROTEIN; ZINC ALPHA 2 GLYCOPROTEIN;

ADIPOCYTE; ADIPOSE TISSUE; ADVANCED CANCER; ARTICLE; BODY COMPOSITION; CACHEXIA; CANCER PATIENT; CANCER SURVIVAL; CHRONIC DISEASE; CHRONIC INFLAMMATION; CYTOKINE RELEASE; DIABETES MELLITUS; GLUCOSE METABOLISM; HIGH RISK PATIENT; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID METABOLISM; LIPOLYSIS; LIPOTOXICITY; MUSCLE MASS; MUSCLE METABOLISM; MUSCLE TISSUE; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; REGULATORY MECHANISM; TREATMENT RESPONSE;

ADIPOSE TISSUE; CACHEXIA; CYTOKINES; DIABETES MELLITUS; ENERGY METABOLISM; EXERCISE; HUMANS; MUSCLE PROTEINS; NEOPLASMS; OBESITY;

EID: 84863817744     PISSN: 08939675     EISSN: 21626448     Source Type: Journal    
DOI: 10.1615/CritRevOncog.v17.i3.40     Document Type: Article

References (73)

1. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011May;12(5):489-95.
2. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009Nov 15;15(22):6973-79.
3. Sherwood LL. Human physiology: from cells to systems. Florence (KY): Brooks Cole; 5 edition (June 2, 2003); ISBN-10:0314092455.
4. Brandt C, Pedersen BK. The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases. J Biomed Biotechnol. 2010;2010:520258.
5. Rennie MJ. Anabolic resistance in critically ill patients. Crit Care Med. 2009 Oct;37(10) Suppl):S398-99.
6. Chesley A, MacDougall JD, Tarnopolsky MA, Atkinson SA, Smith K. Changes in human muscle protein synthesis after resistance exercise. J Appl Physiol. 1992Oct;73(4):1383-88.
7. Phillips SM, Tipton KD, Aarsland A, Wolf SE, Wolfe RR. Mixed muscle protein synthesis and breakdown after resistance exercise in humans. Am J Physiol. 1997Jul;273(1 Pt 1):E99-107.
8. Wilkinson SB, Phillips SM, Atherton PJ, Patel R, Yarasheski KE, Tarnopolsky MA, Rennie MJ. Differential effects of resistance and endurance exercise in the fed state on signalling molecule phosphorylation and protein synthesis in human muscle. J Physiol. 2008Aug 1;586(Pt 15):3701-17.
9. Biolo G, Maggi SP, Williams BD, Tipton KD, Wolfe RR. Increased rates of muscle protein turnover and amino acid transport after resistance exercise in humans. Am J Physiol. 1995Mar;268(3 Pt 1):E514-20.
10. Biolo G, Williams BD, Fleming RY, Wolfe RR. Insulin action on muscle protein kinetics and amino acid transport during recovery after resistance exercise. Diabetes. 1999May;48(5):949-57.
11. Carraro F, Hartl WH, Stuart CA, Layman DK, Jahoor F, Wolfe RR. Whole body and plasma protein synthesis in exercise and recovery in human subjects. Am J Physiol. 1990May;258(5 Pt 1):E821-31.
12. Short KR, Vittone JL, Bigelow ML, Proctor DN, Nair KS. Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am J Physiol Endocrinol Metab. 2004Jan;286(1):E92-101.
13. Weber MA, Krakowski-Roosen H, Schroder L, Kinscherf R, Krix M, Kopp-Schneider A, Essig M, Bachert P, Kauczor HU, Hildebrandt W. Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia. Acta Oncol. 2009;48(1):116-24.
14. Miller BF. Human muscle protein synthesis after physical activity and feeding. Exerc Sport Sci Rev. 2007Apr;35(2):50-55.
15. Glover EI, Phillips SM, Oates BR, Tang JE, Tarnopolsky MA, Selby A, Smith K, Rennie MJ. Immobilization induces anabolic resistance in human myofibrillar protein synthesis with low and high dose amino acid infusion. J Physiol. 2008Dec 15;586(Pt 24):6049-61.
16. Rennie MJ. Anabolic resistance: the effects of aging, sexual dimorphism, and immobilization on human muscle protein turnover. Appl Physiol Nutr Metab. 2009Jun;34(3):377-81.
17. Harris BA. The influence of endurance and resistance exercise on muscle capillarization in the elderly: a review. Acta Physiol Scand. 2005Oct;185(2):89-97.
18. Weber MA, Hildebrandt W, Schroder L, Kin-scherf R, Krix M, Bachert P, Delorme S, Essig M, Kauczor HU, Krakowski-Roosen H. Concentric resistance training increases muscle strength without affecting microcirculation. Eur J Radiol. 2010Mar;73(3):614-21.
19. Clark MG, Rattigan S, Barrett EJ. Nutritive blood flow as an essential element supporting muscle anabolism. Curr Opin Clin Nutr Metab Care. 2006May;9(3):185-89.
20. Buchele G, De Backer D, Vincent JL. The micro circulation in critically-ill patients. Acta Clin Belg. 2007Jan-Feb;62(1):15-20.
21. Nixon DW, Lawson DH, Kutner M, Ansley J, Schwarz M, Heymsfield S, Chawla R, Cartwright TH, Rudman D. Hyperalimentation of the cancer patient with protein-calorie undernutrition. Cancer Res. 1981Jun;41(6):2038-45.
22. Irigaray P, Newby JA, Lacomme S, Belpomme D. Overweight/obesity and cancer genesis: more than a biological link. Biomed Pharmacother. 2007Dec;61(10):665-78.
23. Das SK, Eder S, Schauer S, Diwoky C, Temmel H, Guertl B, Gorkiewicz G, Tamilarasan KP, Kumari P, Trauner M, Zimmermann R, Vesely P, Haemmerle G, Zechner R, Hoefler G. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science. 2011Jul 8;333(6039):233-8.
24. Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA, Sicard A, Rome S, Benis A, Zucker JD, Vidal H, Laville M, Barsh GS, Basdevant A, Stich V, Cancello R, Langin D. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J. 2004Nov;18(14):1657-69.
25. Tadross JA, le Roux CW. The mechanisms of weight loss after bariatric surgery. Int J Obes (Lond). 2009Apr;33(Suppl 1):S28-32.
26. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol. 2003Jun;14(3):281-87.
27. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest. 2000Jul;106(2):171-76.
28. Tisdale MJ. Biology of cachexia. J Natl Cancer Inst. 1997Dec 3;89(23):1763-73.
29. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003Jan 28;107(3):363-69.
30. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol. 1995;13:369-98.
31. Zhang H, Zhang C. Adipose "talks" to distant organs to regulate insulin sensitivity and vascular function. Obesity (Silver Spring). 2010Nov;18(11):2071-76.
32. Hauner H, Petruschke T, Russ M, Rohrig K, Eckel J. Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia. 1995Jul;38(7):764-71.
33. Hube F, Hauner H. The role of TNF-alpha in human adipose tissue: prevention of weight gain at the expense of insulin resistance? Horm Metab Res. 1999Dec;31(12):626-31.
34. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006Mar;17(1):4-12.
35. Miller GD, Nicklas BJ, Fernandez A. Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2011Sep;7(5):618-24.
36. Ceddia RB, Koistinen HA, Zierath JR, Sweeney G. Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J. 2002Aug;16(10):1163-76.
37. Lee Y, Wang MY, Kakuma T, Wang ZW, Babcock E, McCorkle K, Higa M, Zhou YT, Unger RH. Liporegulation in diet-induced obesity. The antis-teatotic role of hyperleptinemia. J Biol Chem. 2001Feb 23;276(8):5629-35.
38. Loffreda S, Yang SQ, Lin HZ, Karp CL, Breng-man ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J. 1998Jan;12(1):57-65.
39. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL. Serum immunoreactiveleptin concentrations in normal-weight and obese humans. N Engl J Med. 1996Feb 1;334(5):292-95.
40. Steinberg GR, Parolin ML, Heigenhauser GJ, Dyck DJ. Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab. 2002Jul;283(1):E187-92.
41. Marcell TJ, McAuley KA, Traustadottir T, Reaven PD. Exercise training is not associated with improved levels of C-reactive protein or adiponectin. Metabolism. 2005Apr;54(4):533-41.
42. Mracek T, Stephens NA, Gao D, Bao Y, Ross JA, Ryden M, Arner P, Trayhurn P, Fearon KC, Bing C. Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastro intestinal cancer patients. Br J Cancer. 2011Feb 1;104(3):441-47.
43. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev. 2008Oct;88(4):1379-406.
44. Quinn LS, Anderson BG, Strait-Bodey L, Stroud AM, Argiles JM. Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab. 2009Jan;296(1):E191-202.
45. Quinn LS, Haugk KL, Grabstein KH. Interleu-kin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology. 1995Aug;136(8):3669-72.
46. Quinn LS, Haugk KL, Damon SE. Interleukin-15 stimulates C2 skeletal myoblast differentiation. Biochem Biophys Res Commun. 1997Oct 9;239(1):6-10.
47. Fuster G, Busquets S, Figueras M, Ametller E, Fontes de Oliveira CC, Olivan M, Grimaldi PA, Argiles JM, Lopez-Soriano FJ. PPARdelta mediates IL15 metabolic actions in myotubes: effects of hyperthermia. Int J Mol Med. 2009Jul;24(1):63-68.
48. Nielsen AR, Mounier R, Plomgaard P, Mortensen OH, Penkowa M, Speerschneider T, Pilegaard H, Pedersen BK. Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fibre type composition. J Physiol. 2007 Oct 1;584(Pt 1):305-12.
49. Busquets S, Figueras M, Almendro V, Lopez-Soriano FJ, Argiles JM. Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine. Biochim Biophys Acta. 2006 Nov;1760(11):1613-17.
50. Meadows KA, Holly JM, Stewart CE. Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts. J Cell Physiol. 2000Jun;183(3):330-37.
51. Franckhauser S, Elias I, Rotter Sopasakis V, Ferre T, Nagaev I, Andersson CX, Agudo J, Ruberte J, Bosch F, Smith U. Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia. 2008Jul;51(7):1306-16.
52. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med. 2002Jan;8(1):75-79.
53. Keller P, Penkowa M, Keller C, Steensberg A, Fischer CP, Giralt M, Hidalgo J, Pedersen BK. Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6. FASEB J. 2005Jul;19(9):1181-83.
54. Nielsen AR, Pedersen BK. The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. Appl Physiol Nutr Metab. 2007Oct;32(5):833-39.
55. Argiles JM, Lopez-Soriano FJ, Busquets S. Therapeutic potential of interleukin-15: a myokine involved in muscle wasting and adiposity. Drug Discov Today. 2009Feb;14(3-4):208-13.
56. Carbo N, Lopez-Soriano J, Costelli P, Busquets S, Alvarez B, Baccino FM, Quinn LS, Lopez-Soriano FJ, Argiles JM. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br J Cancer. 2000Aug;83(4):526-31.
57. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ ACRP30. Nat Med. 2002Jul;8(7):731-37.
58. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes. 2003Jul;52(7):1779-85.
59. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002Nov;8(11):1288-95.
60. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Adi-ponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 2000Sep 12;102(11):1296-301.
61. Smiechowska J, Utech A, Taffet G, Hayes T, Mar-celli M, Garcia JM. Adipokines in patients with cancer anorexia and cachexia. J Investig Med. 2010Mar;58(3):554-59.
62. Kemik O, Kemik AS, Begenik H, Erdur FM, Emre H, Sumer A, Purisa S, Tuzun S, Kotan C. The relationship among acute-phase responce proteins, cytokines, and hormones in various gastrointestinal cancer types patients with cachectic. Hum Exp Toxicol. 2011Jul 29 [Epub ahead of print].[QUERY: Please provide final publication information if available.]
63. Nakajima TE, Yamada Y, Hamano T, Furuta K, Gotoda T, Katai H, Kato K, Hamaguchi T, Shimada Y. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J Gastroenterol. 2009;44(7):685-90.
64. Terzidis A, Sergentanis TN, Antonopoulos G, Syrigos C, Efremidis A, Polyzos A, Dessypris N, Petridou ET. Elevated serum leptin levels: a risk factor for non-small-cell lung cancer? Oncology. 2009;76(1):19-25.
65. Wolf I, Sadetzki S, Kanety H, Kundel Y, Pariente C, Epstein N, Oberman B, Catane R, Kaufman B, Shimon I. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer. 2006Feb15;106(4):966-73.
66. Rennie MJ. Exercise and nutrient-controlled mechanisms involved in maintenance of the musculoskeletal mass. Biochem Soc Trans. 2007Nov;35(Pt 5):1302-5.
67. Muscaritoli M, Molfino A, Gioia G, Laviano A, Rossi Fanelli F. The "parallel pathway": a novel nutritional and metabolic approach to cancer patients. Intern Emerg Med. 2011Apr;6(2):105-12.
68. Hasenberg T, Essenbreis M, Herold A, Post S, Shang E. Early supplementation of parenteral nutrition is capable of improving quality of life, chemotherapy related toxicity and body composition in patients with advanced colorectal carcinoma undergoing palliative treatment: results from a prospective, randomized clinical trial. Colorectal Dis. 2010Oct;12(10 Online):e190-99.
69. Paccagnella A, Morello M, Da Mosto MC, Baruffi C, Marcon ML, Gava A, Baggio V, Lamon S, Babare R, Rosti G, Giometto M, Boscolo-Rizzo P, Kiwanuka E, Tessarin M, Caregaro L, Marchiori C. Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy. Support Care Cancer. 2010Jul;18(7):837-45.
70. Agustsson T, Ryden M, Hoffstedt J, van Harmelen V, Dicker A, Laurencikiene J, Isaksson B, Permert J, Arner P. Mechanism of increased lipolysis in cancer cachexia. Cancer Res. 2007Jun 1;67(11):5531-37.
71. Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis-a highly regulated Fmulti-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res. 2011Jan;50(1):14-27.
72. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010Aug 19;363(8):733-42.
73. Lopez-Soriano J, Chiellini C, Maffei M, Grimaldi PA, Argiles JM. Roles of skeletal muscle and peroxisome proliferator-activated receptors in the development and treatment of obesity. Endocr Rev. 2006May;27(3):318-29.